VKTX ▼ -5.8% - Viking Therapeutics, Inc. $VKTX 200 million stock offering & 200 million convertible senior notes Viking Therapeutics announced a $200 million stock offering alongside a $200 million convertible senior notes offering, which drove shares down 5.8% as investors digested the dilution from the equity raise and the debt addition to the company's capital structure. 23-SEP-2026 05:01 PM ET